Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Biomarkers 2014

David Miyamoto's Biography



David Miyamoto, Instructor in Radiation Oncology, Massachusetts General Hospital/Harvard Medical School

David Miyamoto, MD, PhD is Instructor in Radiation Oncology at Harvard Medical School, attending physician at Massachusetts General Hospital (MGH), and a physician scientist in the MGH Circulating Tumor Cell Center directed by Dr. Daniel Haber. He earned his AB in Chemistry from Harvard College, MD from Harvard Medical School, and PhD in Cell Biology from Harvard University. He is a board-certified radiation oncologist who sees patients in the Bertucci Center for Genitourinary Cancers at the MGH Cancer Center. His research focuses on developing sensitive microfluidic platforms for the detection and molecular analysis of circulating tumor cells (CTCs) in prostate cancer, and the development of novel biomarkers to guide prostate cancer therapy. His research has been supported by the Department of Defense, National Cancer Institute, and the Dana Farber/Harvard Cancer Center.

David Miyamoto Image

Microfluidic Isolation and Molecular Characterization of Circulating Tumor Cells

Tuesday, 25 March 2014 at 16:30

Add to Calendar ▼2014-03-25 16:30:002014-03-25 17:30:00Europe/LondonMicrofluidic Isolation and Molecular Characterization of Circulating Tumor CellsCirculating Biomarkers 2014 in Boston, Massachusetts, USABoston, Massachusetts, USASELECTBIOenquiries@selectbiosciences.com

Through a collaborative effort between bioengineers, biologists, and clinicians, our group at MGH has developed three successive generations of microfluidic devices to efficiently and gently isolate rare circulating tumor cells (CTCs) shed into the blood. Our efforts to molecularly characterize CTCs are leading to new insights into cancer biology and enabling the development of biology-driven biomarkers. I will describe our recent efforts to dissect the molecular and cell biology of CTCs, and the potential of these analyses to non-invasively monitor and predict treatment responses.


Add to Calendar ▼2014-03-24 00:00:002014-03-25 00:00:00Europe/LondonCirculating Biomarkers 2014Circulating Biomarkers 2014 in Boston, Massachusetts, USABoston, Massachusetts, USASELECTBIOenquiries@selectbiosciences.com